scholarly journals The future in glioblastoma treatment

2021 ◽  
Author(s):  
Natasha Kuromoto de Castro ◽  
Luisa Oliveira Wey Rossettini ◽  
Mirto Nelso Prandini
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Immune Responses ◽  
Patient Survival ◽  
Lymphatic Vessels ◽  
Active Immunotherapy ◽  
Good Strategy ◽  
Antitumor Response ◽  
Great Relevance ◽  
Aggressive Tumor

Introduction: Glioblastoma multiforme (GBM) is the most aggressive tumor that affects humans. Surgical treatment based on cytoreduction presents serious limitations. Consequently, treatments that use selective measures, in order to define relevant antigens that retard growth and recurrences, acquire a prominent position. The complex tumor microenvironment and the infiltration into adjacent tissues make surgical therapies, radiotherapy and chemotherapy, approaches still unsatisfactory when the increase in survival rate is evaluated. Studies on central nervous system immunovigilance have found the presence of lymphatic vessels and the perivascular system that allows the presentation of antigens to T4 cells bringing with it great relevance of immunotherapy, and the creation of active immune responses, recruiting the immune system itself to fight the tumor locally or systemically. Objectives: Determine the effectiveness of combining immunotherapy with conventional therapies of treatments in order to prolong the survival of patients with GBM. Methodology: Databases of Springer Link, Oxford academic, PubMed, Biblioteca USP. Results: For an active immunotherapy to be well-defined, it is necessary to have a strong and efficient antigen presentation breaking the state of tumor immune tolerance and activating effector lymphocytes. The use of dendritic cells for this presentation may be a good strategy. Finally, the antitumor response requires coordination between various local and systemic components. Conclusion: The use of immunotherapy in the treatment of GBM continues to expand. Despite several problems, due to immunosuppression mediated by the tumor itself, the immunotherapy brings a hope regarding to the possibility of to increase the immunogenicity and, thus, prolonging patient survival.

Humoral immune responses within the human central nervous system following systemic immunization

1986 ◽  
Vol 11 (3) ◽  
pp. 205-214 ◽  
Author(s):  
Magnhild Sandberg-Wollheim ◽  
Burton Zweiman ◽  
Arnold I. Levinson ◽  
Robert P. Lisak
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Immune Responses ◽  
Human Central Nervous System ◽  
Humoral Immune ◽  
Humoral Immune Responses

scholarly journals Extraparenchymal neurocysticercosis: a challenge in treatment and in clinical management

2020 ◽  
Vol 13 (52) ◽  
pp. 9-18
Author(s):  
Agnès Fleury ◽  
Edda Sciutto
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Clinical Management ◽  
Patient Survival ◽  
Severe Form ◽  
Parasitic Disease ◽  
The Central Nervous System

Neurocysticercosis is a parasitic disease that occurs when cysticerci are installed in the central nervous system. This paper describes the challenge that continues in the treatment of the most severe form of neurocysticercosis that occurs when the parasite is installed outside the parenchyma. The relevance of neuroinflammation control for patient survival and its implications on the effectiveness of the treatment are discussed.

Neuroanatomy and neurophysiology

2021 ◽  
pp. 725-852
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Cervical Vertebrae ◽  
Lymphatic Vessels ◽  
Cell Types ◽  
Cellular Level ◽  
Inhibitory Synapses ◽  
The Central Nervous System ◽  
Emotion Memory ◽  
Different Cell Types

‘Neuroanatomy and neurophysiology’ covers the anatomy and organization of the central nervous system, including the skull and cervical vertebrae, the meninges, the blood and lymphatic vessels, muscles and nerves of the head and neck, and the structures of the eye, ear, and central nervous system. At a cellular level, the different cell types and the mechanism of transmission across synapses are considered, including excitatory and inhibitory synapses. This is followed by a review of the major control and sensory systems (including movement, information processing, locomotion, reflexes, and the main five senses of sight, hearing, touch, taste, and smell). The integration of these processes into higher functions (such as sleep, consciousness and coma, emotion, memory, and ageing) is discussed, along with the causes and treatments of disorders of diseases such as depression, schizophrenia, epilepsy, addiction, and degenerative diseases.

scholarly journals Burkitt's Lymphoma of the Base of the Tongue: A Case Report and Review of the Literature

2007 ◽  
Vol 86 (6) ◽  
pp. 356-360 ◽  
Author(s):  
Steven M. Feinberg ◽  
S.H. Ignatius Ou ◽  
Mai Gu ◽  
Terry Y. Shibuya
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Burkitt’S Lymphoma ◽  
Rapid Diagnosis ◽  
Burkitt's Lymphoma ◽  
Review Of The Literature ◽  
The Third ◽  
Central Nervous System Prophylaxis ◽  
Aggressive Tumor ◽  
Base Of The Tongue

Burkitt's lymphoma is a highly aggressive, mature B cell non-Hodgkin's lymphoma that is rare outside Africa. We report a case of Burkitt's lymphoma presenting as a rapidly expanding tongue-base mass that caused airway obstruction in an 80-year-old Palestinian man living in California. According to our review of the literature, this is only the third reported case of Burkitt's lymphoma arising in the base of the tongue. We also discuss the incidence, epidemiology, genetics, prognosis, and treatment of this malignancy. Because Burkitt's lymphoma is one of the fastest-growing tumors in humans, rapid diagnosis and treatment are important. Treatment involves brief-duration, high-intensity chemotherapy and central nervous system prophylaxis. It is important for the otolaryngologist to recognize this disease and to understand the steps necessary to treat this aggressive tumor.

scholarly journals Prion propagation in mice lacking central nervous system NF-κB signalling

2008 ◽  
Vol 89 (6) ◽  
pp. 1545-1550 ◽  
Author(s):  
C. Julius ◽  
M. Heikenwalder ◽  
P. Schwarz ◽  
A. Marcel ◽  
M. Karin ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Immune Responses ◽  
Published Data ◽  
Histopathological Changes ◽  
Prion Infection ◽  
Prion Propagation ◽  
Proliferation Regulation ◽  
The Impact ◽  
The Brain

Prions induce highly typical histopathological changes including cell death, spongiosis and activation of glia, yet the molecular pathways leading to neurodegeneration remain elusive. Following prion infection, enhanced nuclear factor-κB (NF-κB) activity in the brain parallels the first pathological changes. The NF-κB pathway is essential for proliferation, regulation of apoptosis and immune responses involving induction of inflammation. The IκB kinase (IKK) signalosome is crucial for NF-κB signalling, consisting of the catalytic IKKα/IKKβ subunits and the regulatory IKKγ subunit. This study investigated the impact of NF-κB signalling on prion disease in mouse models with a central nervous system (CNS)-restricted elimination of IKKβ or IKKγ in nearly all neuroectodermal cells, including neurons, astrocytes and oligodendrocytes, and in mice containing a non-phosphorylatable IKKα subunit (IKKα AA/AA). In contrast to previously published data, the observed results showed no evidence supporting the hypothesis that impaired NF-κB signalling in the CNS impacts on prion pathogenesis.

Sign in / Sign up

Export Citation Format

Share Document